Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexidol® Used as an Add-On to Standard Therapy in Older Adults With Vascular Cognitive Impairment, No Dementia
NCT07700615Phase 4Completed
- Sponsor
- Pharmasoft
- Start
- Sep 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
A Phase 4 trial of emoxypine in vascular cognitive impairment (VCI), sponsored by Pharmasoft. Started Sep 2025; status: completed.
02
Drugs
emoxypine
03
Conditions
vascular cognitive impairment (VCI)
Beyond the preview
Go deeper on NCT07700615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700615.